The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2021 | COVID-19 vaccination in CLL
Mazyar Shadman, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, talks on COVID-19 vaccine recommendations for patients with chronic lymphocytic leukemia (CLL), highlighting potential efficacy limitations associated with disease biology. Dr Shadman also gives an overview of existing data on COVID-19 vaccine efficacy in patients with CLL and shares recommendations for vaccination. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.
